High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms.
D000328:Adult; D001772:Blood Cell Count; D001792:Blood Platelets; D001803:Blood Transfusion; D001853:Bone Marrow; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D003556:Cystitis / Q000139:chemically induced; D004341:Drug Evaluation; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D003520:Cyclophosphamide